What is the appropriate workup and management for asymptomatic microscopic hematuria (blood in urine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

All patients with microscopically confirmed hematuria in the absence of a demonstrable benign cause should undergo cystoscopy and imaging, as recommended by the American College of Physicians 1. The initial evaluation of microscopic hematuria should include a comprehensive history, physical examination, and repeat urinalysis to confirm persistence. The definition of microscopic hematuria is three or more red blood cells per high-power field on microscopic evaluation of urinary sediment from two of three properly collected urinalysis specimens, as defined by the American Urological Association 1. Key considerations in the workup of microscopic hematuria include:

  • Cystoscopy for patients over 35 years old or those with risk factors for bladder cancer, such as smoking history, chemical exposures, or prior pelvic radiation 1
  • Upper tract imaging with CT urography for patients with persistent microscopic hematuria without an obvious benign cause 1
  • Laboratory tests, including serum creatinine, estimated glomerular filtration rate, and urine culture, to evaluate for potential underlying conditions such as glomerulonephritis or urinary tract infection 1
  • Nephrology consultation for patients with suspected glomerular disease, based on proteinuria, dysmorphic RBCs, or RBC casts 1 The management of microscopic hematuria depends on the underlying cause, with urologic conditions potentially requiring surgical intervention and glomerular causes potentially requiring immunosuppressive therapy. Patients with negative evaluations should have repeat urinalysis at 6,12, and 24 months, with reconsideration of the complete workup if hematuria persists, as the condition can be the first sign of serious conditions including malignancy, urolithiasis, or glomerulonephritis, though in approximately 70% of cases no specific cause is identified after complete evaluation 1.

From the Research

Microscopic Hematuria Workup

  • The initial evaluation of microscopic hematuria should include renal ultrasound (US) and cystoscopy, along with urinalysis, urine culture, and cytology 2
  • Patients with proteinuria, red cell casts, and elevated serum creatinine levels should be referred promptly to a nephrology subspecialist 3
  • Microscopic hematuria with signs of urinary tract infection should resolve with appropriate treatment of the underlying infection 3

Management of Persistent Microscopic Hematuria

  • Patients with persistent microhematuria after 3 months without definite etiology of the bleeding may still benefit from intravenous urography (IVU) 2
  • The combination of cytology plus intravenous urography, computed tomography, or ultrasonography can be used to evaluate patients with asymptomatic microscopic hematuria or with hematuria persisting after treatment of urinary tract infection 3
  • When urine cytology results are abnormal, cystoscopy should be performed to complete the investigation 3

Diagnostic Findings

  • Abnormalities found in patients with persistent microhematuria may include renal stones, ureteral stones, ureteral tumors, and tumors of the renal pelvis 2
  • The use of IVU in patients with resolved microhematuria is not necessary, as studies have shown that these patients have normal IVU results 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Assessment of microscopic hematuria in adults.

American family physician, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.